when were glp 1 drugs approved History of glucagon-like peptide-1 receptor agonists GLP-1 Genetics: How Genes Affect
Description
Intentional Weight Loss and Obesity-Related Cancer Risk
Glucagon-Like Peptide-1 receptor agonists do not increase aspiration during upper endoscopy in patients with diabetes
The dual GLP-1/glucagon receptor agonist G49 mimics bariatric surgery effects by inducing metabolic rewiring and inter-organ crosstalk
F., & STEP 1 Study Group (2021)
Lippincott Williams & Wilkins, Philadelphia, PA, USA Krishnan A, Hadi Y, Alqahtani SA et al (2023) Cardiovascular outcomes and mortality after bariatric surgery in patients with nonalcoholic fatty liver disease and obesity
